Grünenthal appoints Dr. Jan Adams as Chief Commercial Officer

Share

Aachen, Germany, 30 September 2024 Grünenthal announced today that Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Prior to his role as CSO, he was Head of Strategy and Portfolio at Grünenthal.

Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Copyright: Grünenthal
Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Copyright: Grünenthal

Jan Adams has over two decades of experience in the pharmaceutical and healthcare industry. Since joining Grünenthal in 2017, he has been key in driving the company's transformational journey. Under his leadership, Grünenthal successfully built a state-of-the-art R&D organisation, redefined its R&D strategy, and built an industry-leading pipeline focused on delivering innovative treatments for acute and chronic pain. Before assuming the role of CSO, he served as Head of Strategy and Portfolio, working at the interface between Strategy, R&D, and Commercial. His role was instrumental in several successful M&A projects and Grünenthal’s entry into the U.S. market. Before joining Grünenthal, he held positions with increasing responsibilities at Takeda, McKinsey & Company, and Novartis. Jan Adams started his career as a resident in cardiology. He is a Medical Doctor by training, married, and has two children.

Jan Adams succeeds Janneke van der Kamp, who will leave Grünenthal to pursue an opportunity outside the company.

About Grünenthal

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We focus all our activities and efforts on working towards our vision of a World Free of Pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 27 countries across Europe, Latin America, and the U.S. Our products are available in approx. 100 countries. In 2023, Grünenthal employed around 4,400 people and achieved revenues of €1.8 billion.

More information: https://www.grunenthal.com
Follow us on:
LinkedIn: Grunenthal Group
Instagram: grunenthal

 For further information, please contact:


Florian Dieckmann, Head of Global Corporate Affairs & Communication

Tel.: +49 241 569-2555

Florian.dieckmann@grunenthal.com

Images

Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Copyright: Grünenthal
Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Copyright: Grünenthal
Download

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Tunisia's struggling economy puts democracy at risk, study finds30.9.2024 13:52:30 CEST | Press release

(Tunis/Los Angeles/DNA) – Tunisia's political landscape is undergoing a perilous shift. Once celebrated as the Arab Spring’s democratic success story, the country now faces the grim possibility of sliding back into authoritarianism, a new study warns. As the October 2024 elections loom, analysts warn that President Kaïs Saïed may tighten his grip on power, threatening to reverse the hard-won gains from the 2011 Jasmine Revolution. But what has led Tunisia to this moment? And why has economic stagnation stifled its democratic aspirations? Researchers behind a new Berggruen Governance Index (BGI) report analyze what happened and what may happen next. In late 2010, mass protests erupted in Tunisia, setting the stage for the Jasmine Revolution. This movement, ignited by public outcry against the autocratic rule of Zine El Abidine Ben Ali, became the spark for the wider Arab Spring that swept through North Africa and the Middle East. While many neighboring nations soon experienced civil war

PLAYMOBIL JUNIOR Advent Calendar Delivers on Sustainability: Trays Made from Renewable Materials by PAPACKS®25.9.2024 11:08:07 CEST | Press release

Zirndorf, September 2024 – PLAYMOBIL is staying true to its sustainability strategy with a new eco-friendly innovation. The latest PLAYMOBIL JUNIOR Advent Calendar ditches plastic for renewable materials from PAPACKS®, Europe’s leading producer of molded fiber packaging. This innovative solution eliminates single-use plastic from PLAYMOBIL’s toddler Advent calendars, marking a significant step towards comprehensive sustainability.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye